JAK-STAT, Janus kinase/signal transducers and activators of transcription
ADHD Safety and effectiveness of VYVANSE have been established in pediatric patients with ADHD ages 6 to 17 years [see Dosage and Administration (2.3), Adverse Reactions (6.1), Clinical Pharmacology (12.3), and Clinical Studies (14.1)]
Research applications commonly explored in the literature include: Telomerase activation and telomere length regulation research in non-human models Pineal gland peptide signaling and melatonin-related pathway investigation Cellular senescence and aging biology research frameworks Gene expression modulation studies related to proliferative and regulatory pathways Antioxidant signaling and oxidative stress modeling in non-human research systems The lyophilized vial format allows researchers to evaluate compound stability, reconstitution characteristics, and handling parameters within controlled laboratory settings, supporting consistency across experimental preparation
Other etiologies, such as metformin-induced lactic acidosis and infection, were ruled out with additional testing (a lactic acid level of 1 mmol/l, no signs of acute pancreatitis in CT scan, no signs of pneumonia in a chest X-ray)